Evergreen With Envy: Halozyme’s Subcutaneous Conversions Grow As Rivals Hope To Break In

 
• By Bridget Silverman
  
sparkling evergreen tree
With two recent approvals, subcutaneous conversions continue to sparkle as line extensions for established products. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers